Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
1Doc3 operates one of Latin America's largest AI-driven telemedicine platforms, providing rapid access to general physicians and specialists via text/chat. The service enables symptom assessment, triage, pre-diagnosis, direct doctor connection (often within minutes), e-prescriptions, and home delivery of medications. It has demonstrated significant impact on healthcare accessibility in underserved regions and maintains strong B2B partnerships with insurers and employers.\n\nClinical results are not directly applicable since it does not develop drugs or devices.\n\nThe company reports over 12 million people covered through insurance partners and more than 2 million active users as of recent years.\n\nDuring the COVID pandemic it saw a tenfold increase in consultations; post-pandemic demand remains high due to corporate/insurance partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 1Doc3.